Preparing PAMAM-NK4 nano complexes and examining their in vitro growth suppression effects in breast cancer

Minfeng Liu1, Zhaoze Guo1, Jiangqin Liu1

  • 1Breast Center, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Gland Surgery
|November 4, 2021
PubMed
Abstract

Insights

New polyamidoamine (PAMAM) dendrimers carrying NK4 effectively suppressed breast cancer cell growth and induced apoptosis. This NK4-PAMAM nanoparticle demonstrated therapeutic effects in a nude mice model, reducing tumor volume and mass.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Breast cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
  • Hepatocyte growth factor (HGF) and its fragment NK4 play roles in tumor progression.
  • Polyamidoamine (PAMAM) dendrimers offer potential as drug delivery vehicles for cancer therapy.

Purpose of the Study:

  • To investigate the efficacy of PAMAM-NK4 nanoparticles in suppressing breast cancer cell growth (MDA-MB-231 and MCF-7).
  • To evaluate the therapeutic potential of PAMAM-NK4 in a preclinical nude mouse model of breast cancer.

Main Methods:

  • Construction and in vitro transfection of PAMAM-NK4 nanoparticles.
  • Assessment of NK4 protein expression, cell proliferation (MTT assay), and apoptosis (bead method).
  • Evaluation of therapeutic effects in a MDA-MB-231 tumor xenograft nude mouse model, comparing PAMAM-NK4 treatment with control and doxorubicin.

Main Results:

  • Successful transfection and expression of NK4 protein in breast cancer cells using PAMAM-NK4 nanoparticles.
  • Significant suppression of cell proliferation and induction of apoptosis in vitro.
  • Demonstrated reduction in tumor volume and mass in the treatment group compared to controls, with significant NK4 protein expression.

Conclusions:

  • PAMAM-NK4 nanoparticles effectively inhibit the proliferation of MDA-MB-231 and MCF-7 breast cancer cells.
  • PAMAM-NK4 nanoparticles exhibit therapeutic efficacy in a preclinical model of breast cancer, warranting further investigation.

Related Concept Videos